269
Views
1
CrossRef citations to date
0
Altmetric
This article refers to:
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin

Corrigendum to: Marconescu P, Graviss EA, Musher DM. Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin. Scand J Infect Dis 2012 Aug;44(8):620–2, DOI 10.3109/00365548.2012.669843.

To the Editor:

In reviewing the results presented in our recent report [Citation1], we discovered a tenfold error in dilution of televancin. The MIC50 and MIC90 of the 22 distinct isolates of methicillin-resistant Staphylococcus aureus were each 0.25 μg/ml rather than 2.5 μg/ml as originally reported, and the range was 0.125 to 0.5 μg/ml. These results were confirmed by testing at an independent laboratory (JMI Laboratories, North Liberty, Iowa, Dr. Ron Jones, Director). We apologize for this error. The reported rate of killing by televancin also needs to be interpreted in light of the fact that the concentration utilized was 1 × MIC, not 10 × MIC as originally reported.

Reference

  • Marconescu P, Graviss EA, Musher DM. Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin. Scand J Infect Dis 2012;44:620–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.